Index
1 Market Overview of Nuclear Cardiology
1.1 Nuclear Cardiology Market Overview
1.1.1 Nuclear Cardiology Product Scope
1.1.2 Nuclear Cardiology Market Status and Outlook
1.2 Global Nuclear Cardiology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nuclear Cardiology Market Size by Region (2018-2029)
1.4 Global Nuclear Cardiology Historic Market Size by Region (2018-2023)
1.5 Global Nuclear Cardiology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nuclear Cardiology Market Size (2018-2029)
1.6.1 North America Nuclear Cardiology Market Size (2018-2029)
1.6.2 Europe Nuclear Cardiology Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Cardiology Market Size (2018-2029)
1.6.4 Latin America Nuclear Cardiology Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Cardiology Market Size (2018-2029)
2 Nuclear Cardiology Market by Type
2.1 Introduction
2.1.1 Radiology Devices
2.1.2 Radiology Information Systems (RIS)
2.1.3 Radiopharmaceuticals
2.2 Global Nuclear Cardiology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nuclear Cardiology Historic Market Size by Type (2018-2023)
2.2.2 Global Nuclear Cardiology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nuclear Cardiology Revenue Breakdown by Type (2018-2029)
3 Nuclear Cardiology Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic and Research Institutes
3.1.4 Others
3.2 Global Nuclear Cardiology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nuclear Cardiology Historic Market Size by Application (2018-2023)
3.2.2 Global Nuclear Cardiology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nuclear Cardiology Revenue Breakdown by Application (2018-2029)
4 Nuclear Cardiology Competition Analysis by Players
4.1 Global Nuclear Cardiology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Cardiology as of 2022)
4.3 Date of Key Players Enter into Nuclear Cardiology Market
4.4 Global Top Players Nuclear Cardiology Headquarters and Area Served
4.5 Key Players Nuclear Cardiology Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Cardiology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Nuclear Cardiology Products, Services and Solutions
5.1.4 GE Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Shimadzu
5.2.1 Shimadzu Profile
5.2.2 Shimadzu Main Business
5.2.3 Shimadzu Nuclear Cardiology Products, Services and Solutions
5.2.4 Shimadzu Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.2.5 Shimadzu Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Nuclear Cardiology Products, Services and Solutions
5.3.4 Siemens Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.3.5 Fujifilm Medical Recent Developments
5.4 Fujifilm Medical
5.4.1 Fujifilm Medical Profile
5.4.2 Fujifilm Medical Main Business
5.4.3 Fujifilm Medical Nuclear Cardiology Products, Services and Solutions
5.4.4 Fujifilm Medical Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.4.5 Fujifilm Medical Recent Developments
5.5 Astellas Pharma
5.5.1 Astellas Pharma Profile
5.5.2 Astellas Pharma Main Business
5.5.3 Astellas Pharma Nuclear Cardiology Products, Services and Solutions
5.5.4 Astellas Pharma Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.5.5 Astellas Pharma Recent Developments
5.6 Philips Healthcare
5.6.1 Philips Healthcare Profile
5.6.2 Philips Healthcare Main Business
5.6.3 Philips Healthcare Nuclear Cardiology Products, Services and Solutions
5.6.4 Philips Healthcare Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.6.5 Philips Healthcare Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Nuclear Cardiology Products, Services and Solutions
5.7.4 Medtronic Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 3mensio Medical Imaging
5.8.1 3mensio Medical Imaging Profile
5.8.2 3mensio Medical Imaging Main Business
5.8.3 3mensio Medical Imaging Nuclear Cardiology Products, Services and Solutions
5.8.4 3mensio Medical Imaging Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.8.5 3mensio Medical Imaging Recent Developments
5.9 Bracco Diagnostics
5.9.1 Bracco Diagnostics Profile
5.9.2 Bracco Diagnostics Main Business
5.9.3 Bracco Diagnostics Nuclear Cardiology Products, Services and Solutions
5.9.4 Bracco Diagnostics Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.9.5 Bracco Diagnostics Recent Developments
5.10 UltraSPECT
5.10.1 UltraSPECT Profile
5.10.2 UltraSPECT Main Business
5.10.3 UltraSPECT Nuclear Cardiology Products, Services and Solutions
5.10.4 UltraSPECT Nuclear Cardiology Revenue (US$ Million) & (2018-2023)
5.10.5 UltraSPECT Recent Developments
6 North America
6.1 North America Nuclear Cardiology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nuclear Cardiology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Cardiology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nuclear Cardiology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Cardiology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nuclear Cardiology Market Dynamics
11.1 Nuclear Cardiology Industry Trends
11.2 Nuclear Cardiology Market Drivers
11.3 Nuclear Cardiology Market Challenges
11.4 Nuclear Cardiology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List